Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.
Where does your success begin? With constant development emerging in global marketing scenario, things have become far more complicated then it seems. Smarter marketing solutions opted by the Chief Marketing professionals give the holistic view over the depth of any industry, economically and ideologically. These solutions help organizations improve their measurement and strategic planning. Smarter the solutions, better the outcomes.
MarketsandMarkets is proud to announce the Pharma Cold Chain Logistics - Virtual Conference to be held on 5th - 6th November 2020. Increasing pressure faced by pharmaceutical companies to make their supply chain more efficient, cost effective, focused and more agile has made the industry increasingly competitive in the recent years. With the wide consumption of cold chain logistics in the pharmaceutical industry, efficient temperature controlled logistics is mandatory for quality assurance of drugs. Now with the additional road-blocks and problems due to the pandemic, the pharma supply chain is faring, specifically transportation.
Big data enables us to understand the information contained within the data and also helps us to identify data which is most important for business decision making. The continuous evolution of Big Data technology has led to the growing use of AI, ML and cloud architecture. With newer trends emerging, it is essential to keep track of these and incorporate them into our data strategy.
Single-cell sequencing (SCS) is new effective tool for investigating the evolution and variety of most cancers and role of circulating tumor cells in cancer progression. These methods have started to unravel key questions in cancer biology which have been hard to deal with for bulk tumor measurements. Over the span of 5 years, there has been exceptional development in technology and applications of Single-cell analysis.
Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and, ultimately guide diagnosis and treatment option.
As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.
New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.
Process of marketing does not stop with the product launch but continues thereafter to ensure enhanced customer experience and customized solutions throughout product's lifecycle. Smart marketing solutions opted by organizations contribute to the holistic view over the depth of any industry, economically and contemporarily.
Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation.
Modern supply chains is facing un-precedented stress and are drawing an increased level of scrutiny. It’s time to integrate the business plans and leverage technologies for aligning procurement and supply chain and redefine the bars of success in Retail. An extra-ordinary platform that offers you a power-packed impactful insight from business leaders and innovators for winning on cross-border e-commerce, new payment methods, Digital Logistics, Blockchain, AI, Robotics, Drone and other advanced automation.
Digital Transformation has accelerated immensely in the past few months, Fintech and Blockchain are at the center of this paradigm shift from Traditional Banking to Digital Banking. With the Financial Services and Banking sector bracing themselves for uncertain times, the industries have witnessed advanced innovations, larger investments, and greater productivity. This has led to a rise of Fintech and Blockchain Technology in the Middle East to adopt the changing economy trends.
COVID-19 has changed the business landscape for everyone. In these constantly evolving and changing times, it is essential for business organizations to stay ahead of time and create newer strategies to optimize revenue. Disruptive innovative technologies are now being introduced to overcome challenging times. To gain competitive advantage, businesses must incorporate these technologies along with long-term strategies into their business models.